Trials / Unknown
UnknownNCT06140095
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Region Stockholm · Other Government
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Eight healthy male volunteers will be studied in consecutive sessions regarding the acute effect of evolocumab and atorvastatin on cholesterol and bile metabolism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Evolocumab | See arm description |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2023-11-18
- Last updated
- 2023-11-18
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06140095. Inclusion in this directory is not an endorsement.